Position in ABBV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,340,750,365
+$369,400,002 QoQ
Shares Held
56,741,691
+8.3% QoQ
Ownership
3.21%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 81.60003165221198.ToString("F0")%
Shared 0.8002933997912293.ToString("F0")%
None 17.59967494799679.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $65,165,946,852 across 18 Drug Manufacturers - General names. ABBV ranks #3 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,096,344 | $15,423,270,317 | |
| 2 | LLY |
ELI LILLY & Co
|
13,698,491 | $12,599,461,057 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
56,741,691 | $12,340,750,365 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,972,983 | $6,372,120,116 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
92,475,194 | $5,608,620,506 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
33,992,410 | $4,737,522,172 | |
| 7 | AZN |
Astrazeneca PLC
|
18,590,922 | $3,666,501,627 | |
| 8 | AMGN |
Amgen Inc
|
7,277,837 | $2,560,706,939 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,340,750,365 | 56,741,691 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $11,971,350,363 | 52,393,323 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $13,090,071,286 | 56,534,816 | Shares | Other | 2025-11-26 | |
| 2025-06-30 | $10,620,138,218 | 57,214,407 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $11,472,156,545 | 54,754,470 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,198,194,639 | 51,762,491 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $10,330,593,692 | 52,312,101 | Shares | Sole | 2024-12-26 | |
| 2024-06-30 | $9,186,253,571 | 53,557,915 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $9,368,139,953 | 51,445,030 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $8,061,995,931 | 52,022,946 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $8,232,704,231 | 55,230,808 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,648,969,693 | 56,772,580 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $9,227,294,133 | 57,898,564 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $9,843,699,673 | 60,910,214 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $7,848,467,789 | 58,479,009 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $8,593,904,847 | 56,110,635 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $8,769,210,431 | 54,094,198 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $5,836,415,367 | 43,104,988 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $4,734,776,520 | 43,893,358 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $3,938,006,356 | 34,960,994 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $3,643,204,107 | 33,664,795 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $3,251,519,780 | 30,345,495 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $2,556,802,277 | 29,190,573 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $2,812,921,688 | 28,650,659 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $1,709,763,858 | 22,440,791 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||